| P50 | author | María J Moreno-Aliaga | Q37834424 |
| | Patricia Pérez-Matute | Q83780074 |
| P2093 | author name string | J Alfredo Martínez | |
| | M Pilar Valdecantos | |
| | Pedro Luis Prieto-Hontoria | |
| | Elena Sánchez-Campayo | |
| P2860 | cites work | Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase | Q24310456 |
| | AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity | Q24595845 |
| | Increased oxidative stress in obesity and its impact on metabolic syndrome | Q29012150 |
| | Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 |
| | Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans | Q30438756 |
| | Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication | Q33877846 |
| | The sites and topology of mitochondrial superoxide production | Q33888976 |
| | Do alterations in mitochondrial DNA play a role in breast carcinogenesis? | Q33985107 |
| | Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model | Q34021867 |
| | Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase | Q34512906 |
| | Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. | Q34852226 |
| | Human fatty liver disease: old questions and new insights | Q35588477 |
| | Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. | Q35961703 |
| | Role of mitochondria in non-alcoholic fatty liver disease | Q36849037 |
| | A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues | Q37147048 |
| | Nonalcoholic fatty liver disease: a review and update | Q37681360 |
| | Oxidative stress and the pathogenesis of cholestasis | Q37737637 |
| | Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases | Q37749334 |
| | Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. | Q37749356 |
| | Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review | Q37790095 |
| | Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities | Q37802379 |
| | Obesity affects the liver - the link between adipocytes and hepatocytes. | Q37806012 |
| | Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis | Q37811071 |
| | Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics | Q37817267 |
| | Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. | Q38290879 |
| | Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice | Q38342226 |
| | PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity | Q39754162 |
| | Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria | Q39784182 |
| | Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease | Q42098000 |
| | Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis | Q42748320 |
| | Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different | Q42826082 |
| | Non-invasive diagnosis of liver diseases by breath analysis using an optimized ion-molecule reaction-mass spectrometry approach: a pilot study | Q43163990 |
| | Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats | Q44495010 |
| | Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis | Q44598592 |
| | Effects of a medium chain triglyceride oil mixture and alpha-lipoic acid diet on body composition, antioxidant status, and plasma lipid levels in the Golden Syrian hamster | Q44953664 |
| | Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. | Q45934393 |
| | Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats | Q46336667 |
| | Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase | Q46896340 |
| | Plasma lipid peroxidation and erythrocyte antioxidants status in workers exposed to nickel. | Q50727701 |
| | Whole blood glutathione peroxidase and erythrocyte superoxide dismutase activities, serum trace elements (Se, Cu, Zn) and cardiovascular risk factors in subjects from the city of Ponta Delgada, Island of San Miguel, The Azores Archipelago, Portugal. | Q52805296 |
| | Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? | Q56996899 |
| P433 | issue | 8 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 670-678 | |
| P577 | publication date | 2011-10-15 | |
| P1433 | published in | Biomarkers | Q4915076 |
| P1476 | title | Erythrocyte antioxidant defenses as a potential biomarker of liver mitochondrial status in different oxidative conditions | |
| P478 | volume | 16 | |